Product Images Gabapentin

This is information about Gabapentin Oral Solution containing 250 mg per 5 mL, packaged and distributed by Kesin Pharma Corporation in Oldsmar, FL. The solution is intended for institutional use only and comes in individual 5 mL unit dose cups that must be kept refrigerated between 36°F to 46°F (2°C to 8°C). The expiration date is mentioned as 00-SEP-0000 with LOT number KO0O00000. Further details can be found in the insert provided with the product.*

This text provides information about Gabapentin oral solution, containing 300 mg per 6 mL. The product is specifically intended for institutional use and is packaged and distributed by Kesin Pharma Corporation in Oldsmar, FL. Each package includes 40 x 6 mL unit dose cups that need to be kept refrigerated between 36°F to 46°F (2°C to 8°C). The expiration date is mentioned as 00-SEP-0000, and the lot number is also provided as KO0O00000. Further details and instructions are likely available in the insert provided with the product.*

This is a medical formula for estimating creatinine clearance (CLCr) which takes into account the age in years, weight in kilograms, gender, and serum creatinine level in mg/dL. The formula involves multiplying the age by weight and then adjusting the result by gender (0.85 for female patients) and dividing by the serum creatinine level.*

This text provides information about a pain study with different treatment conditions, including a placebo and a dose of 3600 mg/day of Gabapentin. The table shows the mean pain score at different time points during the study, ranging from baseline to Week 8.*

This text provides a breakdown of the mean pain score over different weeks, including a 3-week Dose Titration Period and a subsequent 4-week Fixed Dose Period. The text also mentions the dosages used, which include Placebo, Gabapentin at 1800 mg/day, and Gabapentin at 2400 mg/day. It seems to be part of a study or experiment tracking pain scores over time with different treatments.*

This text appears to be a list showing percentages and statistical values related to a study or studies comparing the impact of different amounts of PBO and GBP (possibly a study on economics or finance). The percentages range from 0% to 100%, with indication of significance (p<0.01 and p<0.001). The studies are labeled as Study 1 and Study 2, hinting at a comparative analysis.*